KYORIN Pharmaceutical Co., Ltd. (TYO:4569)
Japan · Delayed Price · Currency is JPY 1,171.00
+16.00 (1.39%)
Aug 25, 2026, 3:30 PM JST
KYORIN Pharmaceutical Financials Overview
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 125,682 | 126,257 | 130,087 | 119,532 | 113,270 | 105,534 |
Revenue Growth | -4.71% | -2.94% | 8.83% | 5.53% | 7.33% | 2.56% |
Gross Profit Gross Profit Growth | 50,541 | 51,623 | 59,536 | 51,408 | 50,168 | 49,441 |
Operating Income Operating Income Growth | 2,106 | 3,509 | 12,547 | 6,006 | 5,121 | 5,004 |
Net Income Net Income Growth | 2,172 | 3,448 | 9,086 | 5,322 | 4,723 | 3,932 |
Earnings Per Share EPS Growth | 37.81 | 60.02 | 158.16 | 92.73 | 82.42 | 68.62 |
EPS Growth | -78.91% | -62.05% | 70.55% | 12.51% | 20.11% | -35.86% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Overseas Overseas Growth | 465 | 693 | 8,860 | 386 | 308 | 1,033 |
Unallocated Unallocated Growth | 38,526 | 38,451 | 37,068 | 36,564 | 38,190 | 34,775 |
Japan Japan Growth | 86,691 | 87,113 | 84,158 | 82,581 | 74,770 | 69,725 |
Total Total Growth | 125,682 | 126,257 | 130,086 | 119,531 | 113,268 | 105,533 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 16,955 | 15,081 | 16,514 | 13,985 | 19,394 | 27,494 |
Total Debt Total Debt Growth | 23,243 | 23,785 | 28,439 | 20,946 | 21,277 | 21,624 |
Net Cash (Debt) Net Cash Growth | -6,288 | -8,704 | -11,925 | -6,961 | -1,883 | 5,870 |
Net Cash Growth | - | - | - | - | - | -34.50% |
Net Cash Per Share Net Cash Per Share Growth | -109.46 | -151.51 | -207.58 | -121.29 | -32.86 | 102.44 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | - | 6,381 | 3,506 | 1,549 | 2,008 | 6,346 |
Capital Expenditures CapEx Growth | - | -3,864 | -5,697 | -5,778 | -6,330 | -2,444 |
Free Cash Flow Free Cash Flow Growth | - | 2,517 | -2,191 | -4,229 | -4,322 | 3,902 |
Free Cash Flow Growth | - | - | - | - | - | 247.77% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 40.21% | 40.89% | 45.77% | 43.01% | 44.29% | 46.85% |
Operating Margin | 1.68% | 2.78% | 9.64% | 5.03% | 4.52% | 4.74% |
Pretax Margin | 2.31% | 3.52% | 9.82% | 5.87% | 6.10% | 4.94% |
Profit Margin | 1.73% | 2.73% | 6.98% | 4.45% | 4.17% | 3.73% |
FCF Margin | - | 1.99% | -1.68% | -3.54% | -3.82% | 3.70% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 25, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 25.000 | 57.000 | 52.000 | 52.000 | 52.000 | 52.000 |
Dividend Per Share Growth | -17.54% | 9.62% | 0% | 0% | 0% | -30.67% |
Dividend Yield | 2.18% | 3.46% | 3.59% | 3.08% | 3.37% | 3.33% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 25, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 30.55 | 27.41 | 9.50 | 19.56 | 20.68 | 25.90 |
Forward PE | 42.31 | 20.76 | 20.70 | 17.98 | 18.11 | 30.61 |
P/FCF Ratio | 26.36 | 37.54 | - | - | - | 26.10 |
PS Ratio | 0.53 | 0.75 | 0.66 | 0.87 | 0.86 | 0.97 |